Lentivirus-mediated siRNA knockdown of SPHK1 inhibits proliferation and tumorigenesis of neuroblastoma

References

• MarisJMHogartyMDBagatellRCohnSLNeuroblastomaCSLNeuroblastomaLancet200736995792106212017586306
   PubMed Web of Science ®Google Scholar
• BrodeurGMNeuroblastoma: biological insights into a clinical enigmaNat Rev Cancer20033320321612612655
   PubMed Web of Science ®Google Scholar
• Pediatric Treatment Editorial BoardNeuroblastoma Treatment (PDQ®)Bethesda, MDNational Cancer Institute2014
   Google Scholar
• FrenchKJSchrecengostRSLeeBDDiscovery and evaluation of inhibitors of human sphingosine kinaseCancer Res200363185962596914522923
   PubMed Web of Science ®Google Scholar
• PyneSAdamsDRPyneNJSphingosine l-phosphate and sphingosine kinases in health and disease: Recent advancesProg Lipid Res2016629310626970273
   PubMed Web of Science ®Google Scholar
• TsuchidaJNagahashiMNakajimaMBreast cancer sphingosine-l-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasisJ Surg Res20162051859427621003
   PubMed Web of Science ®Google Scholar
• ZhuWJarmanKELokmanNACIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1Cancer Res201777184823483428729416
   PubMed Web of Science ®Google Scholar
• LiJWuHLiWDownregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signalingOncogene201635425501551427065335
   PubMed Web of Science ®Google Scholar
• XiongHWangJGuanHSphK1 confers resistance to apoptosis in gastric cancer cells by downregulating Bim via stimulating Akt/FoxO3a signalingOncol Rep20143241369137325109605
   PubMed Web of Science ®Google Scholar
• Gomez-BrouchetAPchejetskiDBrizuelaLCritical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-beta peptideMol Pharmacol200772234134917522181
   PubMed Web of Science ®Google Scholar
• PuneetPYapCTWongLSphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsisScience201032859831290129420522778
   PubMed Web of Science ®Google Scholar
• ZamorePDTuschlTSharpPABartelDPRNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervalsCell20001011253310778853
   PubMed Web of Science ®Google Scholar
• DakaAPeerDRNAi-based nanomedicines for targeted personalized therapyAdv Drug Deliv Rev201264131508152122975009
   PubMed Web of Science ®Google Scholar
• SpänkuchBStrebhardtKRNA interference-based gene silencing in mice: the development of a novel therapeutical strategyCurr Pharm Des200511263405341916250844
   PubMed Web of Science ®Google Scholar
• AagaardLRossiJJPrinciples RNAi therapeutics: prospects and challengesAdvanced Drug Deliv Rev2007592–37586
   PubMed Web of Science ®Google Scholar
• MorgensDWDeansRMLiABassikMCSystematic comparison of CRISPR/Cas9 and RNAi screens for essential genesNat Biotechnol201634663463627159373
   PubMed Web of Science ®Google Scholar
• LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) MethodMethods200125440240811846609
   PubMed Web of Science ®Google Scholar
• TangDZhaoXYangTWangCPaclitaxel prodrug based mixed micelles for tumor-targeted chemotherapyRSC Adv201881380389
   Web of Science ®Google Scholar
• ZhaoXTangDYangTWangCFacile preparation of biocompatible nanostructured lipid carrier with ultra-small size as a tumor-penetration delivery systemColloids Surf B Biointerfaces201817035536329940502
   PubMed Web of Science ®Google Scholar
• BieCQLiuXYCaoMRLentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expressionOncotarget2016748793057931827813495
   PubMedGoogle Scholar
• LiuHZhangCXMaYHeHWWangJPShaoRGSphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathwayLife Sci2016151232926944438
   PubMed Web of Science ®Google Scholar
• XuCYLiuSQQinMBSphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cellsInt J Mol Med20173951277128428405684
   PubMed Web of Science ®Google Scholar
• WangSLiangYChangWHuBZhangYTriple negative breast cancer depends on sphingosine kinase 1 (SphK1)/sphingosine-1-phosphate (S1P)/sphingosine 1-phosphate receptor 3 (S1PR3)/notch signaling for metastasisMed Sci Monit2018241912192329605826
   PubMed Web of Science ®Google Scholar
• ShidaDTakabeKKapitonovDMilstienSSpiegelSTargeting SphK1 as a new strategy against cancerCurr Drug Targets20089866267318691013
   PubMed Web of Science ®Google Scholar
• HuangJHuangKLanTCurcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathwayMol Cell Endocrinol2013365223124023127801
   PubMed Web of Science ®Google Scholar
• RosaRMarcianoRMalapelleUSphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer modelsClin Cancer Res201319113814723166225
   PubMed Web of Science ®Google Scholar
• HuWHuangJMahavadiSLiFMurthyKSLentiviral siRNA silencing of sphingosine-1-phosphate receptors S1P1 and S1P2 in smooth muscleBiochem Biophys Res Commun200634341038104416574065
   PubMed Web of Science ®Google Scholar
• AndersonJLiMJPalmerBSafety and efficacy of a lentiviral vector containing three anti-HIV genes-CCR5 ribozyme, tat-rev siRNA, and TAR decoy-in SCID-hu mouse-derived T cellsMol Ther200715611821188
   Web of Science ®Google Scholar
• YuHKortylewskiMPardollDCrosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNat Rev Immunol200771415117186030
   PubMed Web of Science ®Google Scholar
• BaoYLiKGuoYTumor suppressor PRSS8 targets Sphk1/S1P/Stat3/Akt signaling in colorectal cancerOncotarget2016718267802679227050145
   PubMedGoogle Scholar
• KusabaTNakayamaTYamazumiKActivation of STAT3 is a marker of poor prognosis in human colorectal cancerOncol Rep2006156144516685378
   PubMed Web of Science ®Google Scholar
• ZhouJWulfkuhleJZhangHActivation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenanceProc Natl Acad Sci U S A200710441161581616317911267
   PubMed Web of Science ®Google Scholar
• SekiYSuzukiNImaizumiMSTAT3 and MAPK in human lung cancer tissues and suppression of oncogenic growth by JAB and dominant negative STAT3Int J Oncol200424493193415010832
   PubMed Web of Science ®Google Scholar
• YanSLiZThieleCJInhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivoOncotarget20134343344523531921
   PubMedGoogle Scholar